{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,23]],"date-time":"2026-09-23T19:46:57Z","timestamp":1790192817645,"version":"4.1.0"},"reference-count":86,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,1,8]],"date-time":"2026-01-08T00:00:00Z","timestamp":1767830400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,2,4]],"date-time":"2026-02-04T00:00:00Z","timestamp":1770163200000},"content-version":"vor","delay-in-days":27,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Gastroenterol"],"DOI":"10.1186\/s12876-025-04584-6","type":"journal-article","created":{"date-parts":[[2026,1,8]],"date-time":"2026-01-08T08:55:05Z","timestamp":1767862505000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Phenotype-specific determinants of health-related quality of life in Crohn\u2019s disease and ulcerative colitis: a multicenter cross-sectional study"],"prefix":"10.1186","volume":"26","author":[{"given":"Jebrin","family":"Alkrinawi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5577-8499","authenticated-orcid":false,"given":"Mohammad","family":"Alnees","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohammad","family":"Masu\u2019d","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nizar","family":"Abu Hamdeh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yahya Z.","family":"Fraitekh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anwar","family":"Zahran","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Duha","family":"Najajra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abdalaziz","family":"Darwish","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abed AL Rahman","family":"Kabaha","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Asseel","family":"Daoud","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohamed","family":"Khalil","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohammed","family":"Saleh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohammed A.","family":"Barakat","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Osama","family":"Hroub","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ali","family":"Abdullah","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yara","family":"Qassem","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Saleem","family":"Majadleh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Omar","family":"Abu-Khazneh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohammad","family":"Khader","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohammad","family":"Maswadeh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Osama","family":"Ewidat","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Omar Y.","family":"AbuAlayan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qusay","family":"Abdoh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2336-3125","authenticated-orcid":false,"given":"Haitham","family":"Abu Khadija","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,1,8]]},"reference":[{"key":"4584_CR1","doi-asserted-by":"crossref","unstructured":"Kaplan GG. The global burden of IBD: from 2015 to 2025. Nat Rev Gastroenterol Hepatol. 2015 Dec 1 ;12(12):720\u20137. Available from: https:\/\/pubmed.ncbi.nlm.nih.gov\/26323879\/.[cited 2025 Dec 10].","DOI":"10.1038\/nrgastro.2015.150"},{"key":"4584_CR2","doi-asserted-by":"crossref","unstructured":"Ng SC, Shi HY, Hamidi N, Underwood FE, Tang W, Benchimol EI et al. Worldwide incidence and prevalence of inflammatory bowel disease in the 21st century: a systematic review of population-based studies. The Lancet. 2017 Dec 23 ;390(10114):2769\u201378. Available from: https:\/\/pubmed.ncbi.nlm.nih.gov\/29050646\/.[cited 2025 Dec 10].","DOI":"10.1016\/S0140-6736(17)32448-0"},{"key":"4584_CR3","doi-asserted-by":"crossref","unstructured":"Turner D, Ricciuto A, Lewis A, D\u2019Amico F, Dhaliwal J, Griffiths AM et al. STRIDE-II: An Update on the Selecting Therapeutic Targets in Inflammatory Bowel Disease (STRIDE) Initiative of the International Organization for the Study of IBD (IOIBD): Determining Therapeutic Goals for Treat-to-Target strategies in IBD. Gastroenterology. 2021 Apr 1;160(5):1570\u201383. Available from: https:\/\/pubmed.ncbi.nlm.nih.gov\/33359090\/.[cited 2025 Dec 10].","DOI":"10.1053\/j.gastro.2020.12.031"},{"key":"4584_CR4","doi-asserted-by":"crossref","unstructured":"Chen XL, Zhong Lhuan, Wen Y, Liu TW, Li XY, Hou ZK et al. Inflammatory bowel disease-specific health-related quality of life instruments: a systematic review of measurement properties. Health Qual Life Outcomes. 2017 Sep 15 ;15(1). Available from: https:\/\/pubmed.ncbi.nlm.nih.gov\/28915891\/.[cited 2025 Dec 10].","DOI":"10.1186\/s12955-017-0753-2"},{"key":"4584_CR5","unstructured":"The Short Inflammatory Bowel Disease Questionnaire. a quality of life instrument for community physicians managing inflammatory bowel disease. CCRPT Investigators. Canadian Crohn\u2019s Relapse Prevention Trial - PubMed. Available from: https:\/\/pubmed.ncbi.nlm.nih.gov\/8759664\/.[cited 2025 Dec 10]."},{"key":"4584_CR6","doi-asserted-by":"crossref","unstructured":"Jowett SL, Seal CJ, Barton JR, Welfare MR. The short inflammatory bowel disease questionnaire is reliable and responsive to clinically important change in ulcerative colitis. Am J Gastroenterol. 2001 Oct;96(10):2921\u20138. Available from: https:\/\/pubmed.ncbi.nlm.nih.gov\/11693327\/.[cited 2025 Dec 10].","DOI":"10.1111\/j.1572-0241.2001.04682.x"},{"key":"4584_CR7","doi-asserted-by":"crossref","unstructured":"Casellas F, L\u00f3pez-Vivancos J, Casado A, Malagelada JR. Factors affecting health related quality of life of patients with inflammatory bowel disease. Qual Life Res. 2002 Dec;11(8):775\u201381. Available from: https:\/\/pubmed.ncbi.nlm.nih.gov\/12482161\/.[cited 2025 Dec 10].","DOI":"10.1023\/A:1020841601110"},{"key":"4584_CR8","doi-asserted-by":"crossref","unstructured":"Moradkhani A, Beckman LJ, Tabibian JH. Health-related quality of life in inflammatory bowel disease: psychosocial, clinical, socioeconomic, and demographic predictors. J Crohns Colitis. 2013 Jul 1;7(6):467\u201373. Available from: https:\/\/pubmed.ncbi.nlm.nih.gov\/22884758\/.[cited 2025 Dec 10].","DOI":"10.1016\/j.crohns.2012.07.012"},{"key":"4584_CR9","doi-asserted-by":"crossref","unstructured":"Sayegh LN, Haddad F, Bou Jaoude L, Fakhoury-Sayegh N, Heraoui GNHA, Nasrallah Z et al. Nutritional Profile, Disease Severity, and Quality of Life of Patients with Inflammatory Bowel Disease: A Case-Control Study. Nutrients. 2024 Jun 11;16(12). Available from: https:\/\/pubmed.ncbi.nlm.nih.gov\/38931181\/.[cited 2025 Dec 10].","DOI":"10.3390\/nu16121826"},{"issue":"7","key":"4584_CR10","doi-asserted-by":"publisher","first-page":"803","DOI":"10.1016\/j.dld.2021.03.002","volume":"53","author":"A Armuzzi","year":"2021","unstructured":"Armuzzi A, Liguori G. Quality of life in patients with moderate to severe ulcerative colitis and the impact of treatment: A narrative review. Dig Liver Dis. 2021;53(7):803\u20138.","journal-title":"Dig Liver Dis"},{"issue":"3","key":"4584_CR11","doi-asserted-by":"publisher","first-page":"344","DOI":"10.1053\/j.gastro.2022.12.007","volume":"164","author":"S Singh","year":"2023","unstructured":"Singh S, Ananthakrishnan AN, Nguyen NH, Cohen BL, Velayos FS, Weiss JM, et al. AGA clinical practice guideline on the role of biomarkers for the management of ulcerative colitis. Gastroenterology. 2023;164(3):344\u201372.","journal-title":"Gastroenterology"},{"key":"4584_CR12","doi-asserted-by":"publisher","unstructured":"Calvi\u00f1o-Su\u00e1rez C, Ferreiro-Iglesias R, Bast\u00f3n-Rey I, Barreiro-de Acosta M. Role of Quality of Life as Endpoint for Inflammatory Bowel Disease Treatment. Int J Environ Res Public Health. 2021 Jul 4;18(13):7159. https:\/\/doi.org\/10.3390\/ijerph18137159. PMID: 34281095; PMCID: PMC8296948.","DOI":"10.3390\/ijerph18137159"},{"issue":"6","key":"4584_CR13","doi-asserted-by":"publisher","first-page":"1187","DOI":"10.14309\/ajg.0000000000003463","volume":"120","author":"DT Rubin","year":"2025","unstructured":"Rubin DT, Ananthakrishnan AN, Siegel CA, Barnes EL, Long MD. ACG clinical guideline update: ulcerative colitis in adults. Am J Gastroenterol. 2025;120(6):1187\u2013224.","journal-title":"Am J Gastroenterol"},{"key":"4584_CR14","doi-asserted-by":"publisher","first-page":"104","DOI":"10.4103\/jrms.JRMS_975_16","volume":"22","author":"F Habibi","year":"2017","unstructured":"Habibi F, Habibi ME, Gharavinia A, Mahdavi SB, Akbarpour MJ, Baghaei A, et al. Quality of life in inflammatory bowel disease patients: A cross-sectional study. J Res Med Sci. 2017;22:104.","journal-title":"J Res Med Sci"},{"issue":"1","key":"4584_CR15","doi-asserted-by":"publisher","first-page":"107","DOI":"10.5217\/ir.2018.00099","volume":"17","author":"PY Min Ho","year":"2019","unstructured":"Min Ho PY, Hu W, Lee YY, Gao C, Tan YZ, Cheen HH, et al. Health-related quality of life of patients with inflammatory bowel disease in Singapore. Intest Res. 2019;17(1):107\u201318.","journal-title":"Intest Res"},{"issue":"6","key":"4584_CR16","doi-asserted-by":"publisher","first-page":"467","DOI":"10.1016\/j.crohns.2012.07.012","volume":"7","author":"A Moradkhani","year":"2013","unstructured":"Moradkhani A, Beckman LJ, Tabibian JH. Health-related quality of life in inflammatory bowel disease: psychosocial, clinical, socioeconomic, and demographic predictors. J Crohns Colitis. 2013;7(6):467\u201373.","journal-title":"J Crohns Colitis"},{"key":"4584_CR17","doi-asserted-by":"publisher","unstructured":"Kucharzik T, Taylor S, Allocca M, Burisch J, Ellul P, Iacucci M et al. ECCO-ESGAR-ESP-IBUS Guideline on Diagnostics and Monitoring of Patients with Inflammatory Bowel Disease: Part 1. J Crohns Colitis. 2025 Jul 3;19(7):jjaf106. https:\/\/doi.org\/10.1093\/ecco-jcc\/jjaf106. PMID: 40741688.","DOI":"10.1093\/ecco-jcc\/jjaf106"},{"issue":"1","key":"4584_CR18","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1159\/000527846","volume":"104","author":"T Sakurai","year":"2023","unstructured":"Sakurai T, Saruta M. Positioning and usefulness of biomarkers in inflammatory bowel disease. Digestion. 2023;104(1):30\u201341.","journal-title":"Digestion"},{"key":"4584_CR19","doi-asserted-by":"crossref","unstructured":"Plevris N, Fulforth J, Lyons M, Siakavellas SI, Jenkinson PW, Chuah CS et al. Normalization of Fecal Calprotectin Within 12 Months of Diagnosis Is Associated With Reduced Risk of Disease Progression in Patients With Crohn\u2019s Disease. Clinical Gastroenterology and Hepatology. 2021 Sep 1;19(9):1835\u20131844.e6. Available from: https:\/\/pubmed.ncbi.nlm.nih.gov\/32798706\/.[cited 2025 Dec 10].","DOI":"10.1016\/j.cgh.2020.08.022"},{"key":"4584_CR20","doi-asserted-by":"crossref","unstructured":"Kennedy NA, Jones GR, Plevris N, Patenden R, Arnott ID, Lees CW. Association Between Level of Fecal Calprotectin and Progression of Crohn\u2019s Disease. Clinical Gastroenterology and Hepatology. 2019 Oct 1;17(11):2269\u20132276.e4. Available from: https:\/\/pubmed.ncbi.nlm.nih.gov\/30772585\/.[cited 2025 Dec 10].","DOI":"10.1016\/j.cgh.2019.02.017"},{"key":"4584_CR21","doi-asserted-by":"crossref","unstructured":"Dulai PS, Feagan BG, Sands BE, Chen J, Lasch K, Lirio RA. Prognostic Value of Fecal Calprotectin to Inform Treat-to-Target Monitoring in Ulcerative Colitis. Clin Gastroenterol Hepatol. 2023 Feb 1;21(2):456\u2013466.e7. Available from: https:\/\/pubmed.ncbi.nlm.nih.gov\/35934286\/.[cited 2025 Dec 10].","DOI":"10.1016\/j.cgh.2022.07.027"},{"key":"4584_CR22","doi-asserted-by":"crossref","unstructured":"Facciorusso A, Ramai D, Ricciardelli C, Paolillo R, Maida M, Chandan S et al. Prognostic Role of Post-Induction Fecal Calprotectin Levels in Patients with Inflammatory Bowel Disease Treated with Biological Therapies. Biomedicines. 2022 Sep 1;10(9). Available from: https:\/\/pubmed.ncbi.nlm.nih.gov\/36140408\/.[cited 2025 Dec 10].","DOI":"10.3390\/biomedicines10092305"},{"key":"4584_CR23","doi-asserted-by":"publisher","unstructured":"Moran GW, Gordon M, Sinopolou V, Radford SJ, Darie AM, Vuyyuru SK et al. British Society of Gastroenterology guidelines on inflammatory bowel disease in adults: 2025. Gut. 2025 Jun 23;74(Suppl 2):s1-s101. https:\/\/doi.org\/10.1136\/gutjnl-2024-334395. Erratum in: Gut. 2025 Oct 8;74(11):e20.\u00a0https:\/\/doi.org\/10.1136\/gutjnl-2024-334395corr1. PMID: 40550582.","DOI":"10.1136\/gutjnl-2024-334395"},{"issue":"2","key":"4584_CR24","doi-asserted-by":"publisher","first-page":"144","DOI":"10.1093\/ecco-jcc\/jjy113","volume":"13","author":"C Maaser","year":"2019","unstructured":"Maaser C, Sturm A, Vavricka SR, Kucharzik T, Fiorino G, Annese V, et al. ECCO-ESGAR guideline for diagnostic assessment in IBD part 1: initial diagnosis, monitoring of known IBD, detection of complications. J Crohns Colitis. 2019;13(2):144\u201364.","journal-title":"J Crohns Colitis"},{"issue":"5","key":"4584_CR25","doi-asserted-by":"publisher","first-page":"501","DOI":"10.1016\/j.jval.2014.06.005","volume":"17","author":"S Eremenco","year":"2014","unstructured":"Eremenco S, Coons SJ, Paty J, Coyne K, Bennett AV, McEntegart D. PRO data collection in clinical trials using mixed modes: report of the ISPOR PRO mixed modes good research practices task force. Value Health. 2014;17(5):501\u201316.","journal-title":"Value Health"},{"issue":"10","key":"4584_CR26","doi-asserted-by":"publisher","first-page":"2921","DOI":"10.1111\/j.1572-0241.2001.04682.x","volume":"96","author":"SL Jowett","year":"2001","unstructured":"Jowett SL, Seal CJ, Barton JR, Welfare MR. The short inflammatory bowel disease questionnaire is reliable and responsive to clinically important change in ulcerative colitis. Am J Gastroenterol. 2001;96(10):2921\u20138.","journal-title":"Am J Gastroenterol"},{"issue":"1","key":"4584_CR27","doi-asserted-by":"publisher","first-page":"72","DOI":"10.3904\/kjim.2016.324","volume":"34","author":"YW Lee","year":"2019","unstructured":"Lee YW, Lee KM, Lee JM, Chung YY, Kim DB, Kim YJ, et al. The usefulness of fecal calprotectin in assessing inflammatory bowel disease activity. Korean J Intern Med. 2019;34(1):72\u201380.","journal-title":"Korean J Intern Med"},{"key":"4584_CR28","doi-asserted-by":"publisher","first-page":"679264","DOI":"10.3389\/fmed.2021.679264","volume":"8","author":"F Chen","year":"2021","unstructured":"Chen F, Hu Y, Fan YH, Lv B. Clinical value of fecal calprotectin in predicting mucosal healing in patients with ulcerative colitis. Front Med (Lausanne). 2021;8:679264.","journal-title":"Front Med (Lausanne)"},{"key":"4584_CR29","doi-asserted-by":"crossref","unstructured":"Vogelaar lauran, van der Woude J, van\u2019t Spijker A. The impact of biologics on health-related quality of life in patients with inflammatory bowel disease. Clin Exp Gastroenterol. 2009 Sep [cited 2025 Sep 1];2:101. Available from: https:\/\/pubmed.ncbi.nlm.nih.gov\/21694833\/","DOI":"10.2147\/CEG.S4512"},{"issue":"2","key":"4584_CR30","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1161\/CIRCULATIONAHA.114.014508","volume":"131","author":"GS Collins","year":"2015","unstructured":"Collins GS, Reitsma JB, Altman DG, Moons KGM. Transparent reporting of a multivariable prediction model for individual prognosis or diagnosis (TRIPOD). Circulation. 2015;131(2):211\u20139.","journal-title":"Circulation"},{"issue":"3","key":"4584_CR31","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1097\/01.MIB.0000217768.75519.32","volume":"12","author":"T Hlavaty","year":"2006","unstructured":"Hlavaty T, Persoons P, Vermeire S, Ferrante M, Pierik M, Van Assche G, et al. Evaluation of short-term responsiveness and cutoff values of inflammatory bowel disease questionnaire in crohn\u2019s disease. Inflamm Bowel Dis. 2006;12(3):199\u2013204.","journal-title":"Inflamm Bowel Dis"},{"issue":"2","key":"4584_CR32","doi-asserted-by":"publisher","first-page":"287","DOI":"10.1016\/0016-5085(94)90585-1","volume":"106","author":"EJ Irvine","year":"1994","unstructured":"Irvine EJ, Feagan B, Rochon J, Archambault A, Fedorak RN, Groll A, et al. Quality of life: a valid and reliable measure of therapeutic efficacy in the treatment of inflammatory bowel disease. Canadian crohn\u2019s relapse prevention trial study group. Gastroenterology. 1994;106(2):287\u201396.","journal-title":"Gastroenterology"},{"key":"4584_CR33","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/1471-230X-2-1","volume":"2","author":"AG Pallis","year":"2002","unstructured":"Pallis AG, Vlachonikolis IG, Mouzas IA. Assessing health-related quality of life in patients with inflammatory bowel disease, in Crete, Greece. BMC Gastroenterol. 2002;2:1.","journal-title":"BMC Gastroenterol"},{"issue":"2","key":"4584_CR34","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1111\/j.1365-2036.2010.04347.x","volume":"32","author":"DR van Langenberg","year":"2010","unstructured":"van Langenberg DR, Gibson PR. Systematic review: fatigue in inflammatory bowel disease. Aliment Pharmacol Ther. 2010;32(2):131\u201343.","journal-title":"Aliment Pharmacol Ther"},{"issue":"16","key":"4584_CR35","doi-asserted-by":"publisher","first-page":"e3477","DOI":"10.1097\/MD.0000000000003477","volume":"95","author":"A Gauss","year":"2016","unstructured":"Gauss A, Geiss T, Hinz U, Schaefert R, Zwickel P, Zawierucha A, et al. Quality of life is related to fecal calprotectin concentrations in colonic Crohn disease and ulcerative Colitis, but not in ileal Crohn disease. Medicine. 2016;95(16):e3477.","journal-title":"Medicine"},{"issue":"6","key":"4584_CR36","doi-asserted-by":"publisher","first-page":"694","DOI":"10.3109\/00365521.2011.560680","volume":"46","author":"MD Jensen","year":"2011","unstructured":"Jensen MD, Kjeldsen J, Nathan T. Fecal calprotectin is equally sensitive in crohn\u2019s disease affecting the small bowel and colon. Scand J Gastroenterol. 2011;46(6):694\u2013700.","journal-title":"Scand J Gastroenterol"},{"issue":"5","key":"4584_CR37","doi-asserted-by":"publisher","first-page":"931","DOI":"10.1007\/BF02064179","volume":"40","author":"JW Singleton","year":"1995","unstructured":"Singleton JW, Hanauer S, Robinson M. Quality-of-life results of double-blind, placebo-controlled trial of Mesalamine in patients with crohn\u2019s disease. Dig Dis Sci. 1995;40(5):931\u20135.","journal-title":"Dig Dis Sci"},{"issue":"9","key":"4584_CR38","first-page":"CD003715","volume":"9","author":"AK Akobeng","year":"2016","unstructured":"Akobeng AK, Zhang D, Gordon M, MacDonald JK. Oral 5-aminosalicylic acid for maintenance of medically-induced remission in crohn\u2019s disease. Cochrane Database Syst Rev. 2016;9(9):CD003715.","journal-title":"Cochrane Database Syst Rev"},{"issue":"1","key":"4584_CR39","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1016\/j.jiph.2016.02.008","volume":"10","author":"AAE Mahalli","year":"2017","unstructured":"Mahalli AAE, Alharthi HMA. Assessment of health-related quality of life of patients with inflammatory bowel diseases in Eastern Province, Saudi Arabia. J Infect Public Health. 2017;10(1):93\u2013101.","journal-title":"J Infect Public Health"},{"issue":"7","key":"4584_CR40","doi-asserted-by":"publisher","first-page":"e0181435","DOI":"10.1371\/journal.pone.0181435","volume":"12","author":"A Villoria","year":"2017","unstructured":"Villoria A, Garc\u00eda V, Dosal A, Moreno L, Montserrat A, Figuerola A, et al. Fatigue in out-patients with inflammatory bowel disease: prevalence and predictive factors. PLoS ONE. 2017;12(7):e0181435.","journal-title":"PLoS ONE"},{"key":"4584_CR41","doi-asserted-by":"publisher","unstructured":"Hu X, Li J, Sun Y, Wu D, Zhao T, Ma M et al. Combined use of CDAI and blood indices for assessing endoscopic activity in ileocolic Crohn\u2019s disease. BMC Gastroenterol [Internet]. 2023;23(1):337. Available from: https:\/\/doi.org\/10.1186\/s12876-023-02968-0","DOI":"10.1186\/s12876-023-02968-0"},{"key":"4584_CR42","doi-asserted-by":"crossref","unstructured":"Huang JW, Zhan M, Li Q kun, Zou S fang, Cao H, WU D sheng (2024) et al. Systemic inflammatory markers are not optimal for the predicting of disease activity in Crohn's disease patients. 10.21203\/rs.3.rs-5263129\/v1.","DOI":"10.21203\/rs.3.rs-5263129\/v1"},{"issue":"1","key":"4584_CR43","doi-asserted-by":"publisher","first-page":"337","DOI":"10.1186\/s12876-023-02968-0","volume":"23","author":"X Hu","year":"2023","unstructured":"Hu X, Li J, Sun Y, Wu D, Zhao T, Ma M, et al. Combined use of CDAI and blood indices for assessing endoscopic activity in Ileocolic crohn\u2019s disease. BMC Gastroenterol. 2023;23(1):337.","journal-title":"BMC Gastroenterol"},{"issue":"3","key":"4584_CR44","first-page":"243","volume":"26","author":"M Kalafateli","year":"2013","unstructured":"Kalafateli M, Triantos C, Theocharis G, Giannakopoulou D, Koutroumpakis E, Chronis A, et al. Health-related quality of life in patients with inflammatory bowel disease: a single-center experience. Ann Gastroenterol. 2013;26(3):243\u20138.","journal-title":"Ann Gastroenterol"},{"issue":"8","key":"4584_CR45","first-page":"e28502","volume":"14","author":"MA Mitropoulou","year":"2022","unstructured":"Mitropoulou MA, Fradelos EC, Lee KY, Malli F, Tsaras K, Christodoulou NG, et al. Quality of life in patients with inflammatory bowel disease: importance of psychological symptoms. Cureus. 2022;14(8):e28502.","journal-title":"Cureus"},{"issue":"11","key":"4584_CR46","doi-asserted-by":"publisher","first-page":"1075","DOI":"10.1097\/00042737-199611000-00009","volume":"8","author":"MG Russel","year":"1996","unstructured":"Russel MG, Nieman FH, Bergers JM, Stockbr\u00fcgger RW. Cigarette smoking and quality of life in patients with inflammatory bowel disease. South Limburg IBD study group. Eur J Gastroenterol Hepatol. 1996;8(11):1075\u201381.","journal-title":"Eur J Gastroenterol Hepatol"},{"key":"4584_CR47","doi-asserted-by":"publisher","unstructured":"Herrero-Rodr\u00edguez S, Mart\u00edn-Cordero L, Mayordomo R, G\u00e1lvez I, Ortega E et al. Sex-based differences in the relationship between health-related quality of life, physical activity, and inflammatory markers in people with Crohn's disease. Gastroenterol Hepatol. 2025 May 30:502494. English, Spanish. https:\/\/doi.org\/10.1016\/j.gastrohep.2025.502494. Epub ahead of print. PMID: 40451333.","DOI":"10.1016\/j.gastrohep.2025.502494"},{"issue":"6","key":"4584_CR48","doi-asserted-by":"publisher","first-page":"352","DOI":"10.1177\/1756283X15592585","volume":"8","author":"F Ha","year":"2015","unstructured":"Ha F, Khalil H. Crohn\u2019s disease: a clinical update. Th Adv Gastroenterol. 2015;8(6):352\u20139.","journal-title":"Th Adv Gastroenterol"},{"issue":"1","key":"4584_CR49","doi-asserted-by":"publisher","first-page":"62","DOI":"10.5217\/ir.2019.09156","volume":"19","author":"Y Jeong","year":"2021","unstructured":"Jeong Y, Jeon SR, Kim HG, Moon JR, Lee TH, Jang JY, et al. The role of platelet to lymphocyte ratio and neutrophil to lymphocyte ratio in ulcerative colitis. Intest Res. 2021;19(1):62\u201370.","journal-title":"Intest Res"},{"key":"4584_CR50","doi-asserted-by":"publisher","unstructured":"Tan S, Yang X, Mu X, Liu S, Wang Y, Li Y et al. The predictive role of peripheral serum inflammatory markers NLR, PLR, and LMR in ulcerative colitis and Crohn's disease: a systematic review and meta-analysis. Front Immunol. 2025 Jul 25;16:1623899. https:\/\/doi.org\/10.3389\/fimmu.2025.1623899. PMID: 40881709; PMCID: PMC12381567.","DOI":"10.3389\/fimmu.2025.1623899"},{"issue":"1","key":"4584_CR51","first-page":"1","volume":"2","author":"Y Thaker","year":"2016","unstructured":"Thaker Y, Moon A, Afzali A. Clinical gastroenterology and treatment ClinMed. J Clin Gastroenterol. 2016;2(1):1\u20135.","journal-title":"J Clin Gastroenterol"},{"key":"4584_CR52","doi-asserted-by":"publisher","first-page":"785","DOI":"10.1515\/med-2019-0092","volume":"14","author":"V Straksyte","year":"2019","unstructured":"Straksyte V, Kiudelis G, Gineikiene I, Janciauskas D, Basevicius A, Lukosevicius S, et al. Lemann index for assessment of crohn\u2019s disease: correlation with the quality of Life, endoscopic disease activity, magnetic resonance index of activity and C- reactive protein. Open Med (Wars). 2019;14:785\u201391.","journal-title":"Open Med (Wars)"},{"issue":"6","key":"4584_CR53","doi-asserted-by":"publisher","first-page":"1325","DOI":"10.2214\/ajr.177.6.1771325","volume":"177","author":"DM Koh","year":"2001","unstructured":"Koh DM, Miao Y, Chinn RJ, Amin Z, Zeegen R, Westaby D, et al. MR imaging evaluation of the activity of crohn\u2019s disease. AJR Am J Roentgenol. 2001;177(6):1325\u201332.","journal-title":"AJR Am J Roentgenol"},{"key":"4584_CR54","doi-asserted-by":"publisher","unstructured":"Lungaro L, Costanzini A, Manza F, Barbalinardo M, Gentili D, Guarino M et al. Impact of Female Gender in Inflammatory Bowel Diseases: A Narrative Review. J Pers Med. 2023 Jan 17;13(2):165. https:\/\/doi.org\/10.3390\/jpm13020165. PMID: 36836400; PMCID: PMC9958616.","DOI":"10.3390\/jpm13020165"},{"key":"4584_CR55","doi-asserted-by":"publisher","unstructured":"Moradkhani A, Beckman LJ, Tabibian JH. Health-related quality of life in inflammatory bowel disease: psychosocial, clinical, socioeconomic, and demographic predictors. J Crohns Colitis. 2013 Jul;7(6):467\u201373. https:\/\/doi.org\/10.1016\/j.crohns.2012.07.012. Epub 2012 Aug 10. PMID: 22884758.","DOI":"10.1016\/j.crohns.2012.07.012"},{"issue":"3","key":"4584_CR56","doi-asserted-by":"publisher","first-page":"433","DOI":"10.1016\/j.gie.2005.08.011","volume":"63","author":"P Rutgeerts","year":"2006","unstructured":"Rutgeerts P, Diamond RH, Bala M, Olson A, Lichtenstein GR, Bao W, et al. Scheduled maintenance treatment with Infliximab is superior to episodic treatment for the healing of mucosal ulceration associated with crohn\u2019s disease. Gastrointest Endosc. 2006;63(3):433\u201342. quiz 464.","journal-title":"Gastrointest Endosc"},{"issue":"5","key":"4584_CR57","first-page":"527","volume":"37","author":"S Alsakarneh","year":"2024","unstructured":"Alsakarneh S, Ahmed M, Jaber F, Abuassi M, Mourad FH, Francis FF, et al. Inflammatory bowel disease burden in the middle East and North Africa region: a comprehensive analysis of incidence, prevalence, and mortality from 1990\u20132019. Ann Gastroenterol. 2024;37(5):527\u201335.","journal-title":"Ann Gastroenterol"},{"issue":"Suppl","key":"4584_CR58","doi-asserted-by":"publisher","first-page":"S48","DOI":"10.1016\/S0140-6736(21)01534-8","volume":"398","author":"T Smerat","year":"2021","unstructured":"Smerat T, Khdour M, Abdoh Q, Hallak H. Assessment of health-related quality of life in patients with inflammatory bowel disease in occupied Palestinian territory: a correlation cross-sectional study. Lancet. 2021;398(Suppl):S48.","journal-title":"Lancet"},{"issue":"2","key":"4584_CR59","doi-asserted-by":"publisher","first-page":"402","DOI":"10.1053\/j.gastro.2003.11.014","volume":"126","author":"P Rutgeerts","year":"2004","unstructured":"Rutgeerts P, Feagan BG, Lichtenstein GR, Mayer LF, Schreiber S, Colombel JF, et al. Comparison of scheduled and episodic treatment strategies of Infliximab in crohn\u2019s disease. Gastroenterology. 2004;126(2):402\u201313.","journal-title":"Gastroenterology"},{"key":"4584_CR60","doi-asserted-by":"publisher","first-page":"103320","DOI":"10.1016\/j.eclinm.2025.103320","volume":"85","author":"MS Beni\u0107","year":"2025","unstructured":"Beni\u0107 MS, Gilja\u010da V, Belan\u010di\u0107 A, Kadi\u0107 AJ, Vlahovi\u0107-Pal\u010devski V. The impact of biological interventions on health-related quality of life in adults with crohn\u2019s disease: a systematic review with meta-analysis. EClinicalMedicine. 2025;85:103320.","journal-title":"EClinicalMedicine"},{"issue":"1","key":"4584_CR61","doi-asserted-by":"publisher","first-page":"45","DOI":"10.5217\/ir.2019.00135","volume":"19","author":"R Keller","year":"2021","unstructured":"Keller R, Mazurak N, Fantasia L, Fusco S, Malek NP, Wehkamp J, et al. Quality of life in inflammatory bowel diseases: it is not all about the bowel. Intest Res. 2021;19(1):45\u201352.","journal-title":"Intest Res"},{"issue":"10","key":"4584_CR62","doi-asserted-by":"publisher","first-page":"912","DOI":"10.1016\/S1542-3565(04)00414-8","volume":"2","author":"BE Sands","year":"2004","unstructured":"Sands BE, Blank MA, Patel K, van Deventer SJ. Long-term treatment of rectovaginal fistulas in crohn\u2019s disease: response to Infliximab in the ACCENT II study. Clin Gastroenterol Hepatol. 2004;2(10):912\u201320.","journal-title":"Clin Gastroenterol Hepatol"},{"key":"4584_CR63","doi-asserted-by":"publisher","unstructured":"Hebuterne X, Lemann M, Coteur G, Ernault E, Colombel JF. Health-related quality of life improvements in patients with active Crohn\u2019s disease following treatment with certolizumab pegol in the MUSIC study (NCT00297648). Inflamm Bowel Dis. 2011;17(Suppl 1):S46. https:\/\/doi.org\/10.1093\/ibd\/17.supplement1.S46a.","DOI":"10.1093\/ibd\/17.supplement1.S46a"},{"issue":"2","key":"4584_CR64","doi-asserted-by":"publisher","first-page":"250","DOI":"10.1136\/gut.2003.037390","volume":"54","author":"AG Schreyer","year":"2005","unstructured":"Schreyer AG, Rath HC, Kikinis R, V\u00f6lk M, Sch\u00f6lmerich J, Feuerbach S, et al. Comparison of magnetic resonance imaging colonography with conventional colonoscopy for the assessment of intestinal inflammation in patients with inflammatory bowel disease: a feasibility study. Gut. 2005;54(2):250\u20136.","journal-title":"Gut"},{"issue":"3","key":"4584_CR65","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1093\/gastro\/gou026","volume":"2","author":"P Deepak","year":"2014","unstructured":"Deepak P, Bruining DH. Radiographical evaluation of ulcerative colitis. Gastroenterol Rep (Oxf). 2014;2(3):169\u201377.","journal-title":"Gastroenterol Rep (Oxf)"},{"key":"4584_CR66","doi-asserted-by":"crossref","unstructured":"Van der Have M, van der Aalst KS, Kaptein AA, Leenders M, Siersema PD, Oldenburg B et al. Determinants of health-related quality of life in Crohn\u2019s disease: a systematic review and meta-analysis. J Crohns Colitis. 2014 Feb 1;8(2):93\u2013106. Available from: https:\/\/pubmed.ncbi.nlm.nih.gov\/23746864\/.[cited 2025 Dec 10].","DOI":"10.1016\/j.crohns.2013.04.007"},{"key":"4584_CR67","doi-asserted-by":"crossref","unstructured":"Ho PYM, Hu W, Lee YY, Gao C, Tan YZ, Cheen HH et al. Health-related quality of life of patients with inflammatory bowel disease in Singapore. Intest Res. 2019 Jan 1;17(1):107\u201318. Available from: https:\/\/pubmed.ncbi.nlm.nih.gov\/30419638\/.[cited 2025 Dec 10].","DOI":"10.5217\/ir.2018.00099"},{"key":"4584_CR68","doi-asserted-by":"publisher","unstructured":"Lee JW. Ulcerative Colitis and Patient's Quality of Life, Especially in Early Stage. Gut Liver. 2022 May 15;16(3):317\u2013318. https:\/\/doi.org\/10.5009\/gnl220181. PMID: 35551102; PMCID: PMC9099387.","DOI":"10.5009\/gnl220181"},{"issue":"1","key":"4584_CR69","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1002\/jgh3.12005","volume":"1","author":"A Goyal","year":"2017","unstructured":"Goyal A, Ghoshal UC, Nath A, Jindal S, Mohindra S. Pulmonary function in patients with ulcerative colitis and its relationship with disease severity. JGH Open. 2017;1(1):32\u20137.","journal-title":"JGH Open"},{"issue":"8","key":"4584_CR70","doi-asserted-by":"publisher","first-page":"1760","DOI":"10.1016\/j.cgh.2019.09.021","volume":"18","author":"C Ma","year":"2020","unstructured":"Ma C, Sandborn WJ, D\u2019Haens GR, Zou G, Stitt LW, Singh S, et al. Discordance between Patient-Reported outcomes and mucosal inflammation in patients with mild to moderate ulcerative colitis. Clin Gastroenterol Hepatol. 2020;18(8):1760\u2013e17681.","journal-title":"Clin Gastroenterol Hepatol"},{"issue":"11","key":"4584_CR71","doi-asserted-by":"publisher","first-page":"981","DOI":"10.1016\/S2468-1253(24)00200-0","volume":"9","author":"MC Choy","year":"2024","unstructured":"Choy MC, Li Wai Suen CFD, Con D, Boyd K, Pena R, Burrell K, et al. Intensified versus standard dose Infliximab induction therapy for steroid-refractory acute severe ulcerative colitis (PREDICT-UC): an open-label, multicentre, randomised controlled trial. Lancet Gastroenterol Hepatol. 2024;9(11):981\u201396.","journal-title":"Lancet Gastroenterol Hepatol"},{"key":"4584_CR72","doi-asserted-by":"publisher","unstructured":"B\u0105k-Drabik K, Malik M, Gwo\u017adziewicz K, Jarzumbek A, Krakowczyk H, G\u0142owinkowska M, Adamczyk P. Pulmonary Function in Paediatric Patients with Inflammatory Bowel Disease. J Clin Med. 2022 Oct 16;11(20):6095. https:\/\/doi.org\/10.3390\/jcm11206095. PMID: 36294415; PMCID: PMC9604826.","DOI":"10.3390\/jcm11206095"},{"key":"4584_CR73","doi-asserted-by":"crossref","unstructured":"Nicol\u00f2 A, Massaroni C, Schena E, Sacchetti M. The Importance of Respiratory Rate Monitoring: From Healthcare to Sport and Exercise. Sensors (Basel). 2020 Nov 1;20(21):1\u201345. Available from: https:\/\/pubmed.ncbi.nlm.nih.gov\/33182463\/.[cited 2025 Dec 10].","DOI":"10.3390\/s20216396"},{"key":"4584_CR74","doi-asserted-by":"crossref","unstructured":"Kaplan J, Klee D, Oken B. Respiration rate during a stress task moderates neuroticism and perceived stress in older adults. Current issues in personality psychology. 2022;10(4):299\u2013310. Available from: https:\/\/pubmed.ncbi.nlm.nih.gov\/38013730\/.[cited 2025 Dec 10].","DOI":"10.5114\/cipp.2022.114143"},{"key":"4584_CR75","doi-asserted-by":"crossref","unstructured":"Cavalli CAM, Gabbiadini R, Dal Buono A, Quadarella A, De Marco A, Repici A et al. Lung Involvement in Inflammatory Bowel Diseases: Shared Pathways and Unwanted Connections. J Clin Med. 2023 Oct 1;12(19). Available from: https:\/\/pubmed.ncbi.nlm.nih.gov\/37835065\/.[cited 2025 Dec 10].","DOI":"10.3390\/jcm12196419"},{"key":"4584_CR76","doi-asserted-by":"crossref","unstructured":"Valentin S, Renel B, Manneville F, Caron B, Choukour M, Guillaumot A et al. Prevalence of and Factors Associated with Respiratory Symptoms Among Patients with Inflammatory Bowel Disease: A Prospective Study. Inflamm Bowel Dis. 2023 Feb 1 [cited 2025 Dec 10];29(2):207\u201316. Available from: https:\/\/pubmed.ncbi.nlm.nih.gov\/35394504\/","DOI":"10.1093\/ibd\/izac062"},{"issue":"2","key":"4584_CR77","doi-asserted-by":"publisher","first-page":"283","DOI":"10.1097\/MIB.0000000000001008","volume":"23","author":"G Velonias","year":"2017","unstructured":"Velonias G, Conway G, Andrews E, Garber JJ, Khalili H, Yajnik V, et al. Older Age- and Health-related quality of life in inflammatory bowel diseases. Inflamm Bowel Dis. 2017;23(2):283\u20138.","journal-title":"Inflamm Bowel Dis"},{"issue":"11\u201312","key":"4584_CR78","doi-asserted-by":"publisher","first-page":"1278","DOI":"10.1111\/j.1365-2036.2008.03854.x","volume":"28","author":"EJ Irvine","year":"2008","unstructured":"Irvine EJ, Yeh CH, Ramsey D, Stirling AL, Higgins PDR. The effect of mesalazine therapy on quality of life in patients with mildly and moderately active ulcerative colitis. Aliment Pharmacol Ther. 2008;28(11\u201312):1278\u201386.","journal-title":"Aliment Pharmacol Ther"},{"issue":"12","key":"4584_CR79","doi-asserted-by":"publisher","first-page":"827","DOI":"10.1155\/2007\/862917","volume":"21","author":"SB Hanauer","year":"2007","unstructured":"Hanauer SB, Sandborn WJ, Dallaire C, Archambault A, Yacyshyn B, Yeh C, et al. Delayed-release oral Mesalamine 4.8\u00a0g\/day (800\u00a0mg tablets) compared to 2.4\u00a0g\/day (400\u00a0mg tablets) for the treatment of mildly to moderately active ulcerative colitis: the ASCEND I trial. Can J Gastroenterol. 2007;21(12):827\u201334.","journal-title":"Can J Gastroenterol"},{"key":"4584_CR80","doi-asserted-by":"publisher","unstructured":"Kurimoto N, Nishida Y, Hosomi S, Itani S, Kobayashi Y, Nakata R et al. Neutrophil-to-lymphocyte ratio may predict clinical relapse in ulcerative colitis patients with mucosal healing. PLoS One [Internet]. 2023;18(1 January):1\u201311. Available from: https:\/\/doi.org\/10.1371\/journal.pone.0280252","DOI":"10.1371\/journal.pone.0280252"},{"issue":"1","key":"4584_CR81","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1159\/000535889","volume":"9","author":"H Kiyohara","year":"2024","unstructured":"Kiyohara H, Yamazaki H, Moriya K, Akimoto N, Kawai S, Takenaka K, et al. White blood cell counts and future relapse in ulcerative colitis under Low-Dose thiopurine treatment in Real-World practice: A 3-Year Japanese Multi-Center retrospective cohort study. Inflamm Intest Dis. 2024;9(1):1\u201310.","journal-title":"Inflamm Intest Dis"},{"issue":"3","key":"4584_CR82","doi-asserted-by":"publisher","first-page":"384","DOI":"10.5009\/gnl210141","volume":"16","author":"IH Jo","year":"2022","unstructured":"Jo IH, Lee KM, Kim DB, Kim JW, Lee J, Jeen YT, et al. Quality of life in newly diagnosed Moderate-to-Severe ulcerative colitis: changes in the MOSAIK cohort over 1 year. Gut Liver. 2022;16(3):384\u201395.","journal-title":"Gut Liver"},{"issue":"1","key":"4584_CR83","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1002\/ueg2.12351","volume":"11","author":"J He","year":"2023","unstructured":"He J, Zhang S, Qiu Y, Liu F, Liu Z, Tan J, et al. Ulcerative colitis increases risk of hypertension in a UK biobank cohort study. United Eur Gastroenterol J. 2023;11(1):19\u201330.","journal-title":"United Eur Gastroenterol J"},{"issue":"42","key":"4584_CR84","doi-asserted-by":"publisher","first-page":"e27551","DOI":"10.1097\/MD.0000000000027551","volume":"100","author":"L Ma","year":"2021","unstructured":"Ma L, Pang X, Ji G, Ma X, Li J, Chang Y, et al. Application of the neutrophil to lymphocyte ratio in the diagnosis and activity determination of ulcerative colitis: A meta-analysis and systematic review. Medicine. 2021;100(42):e27551.","journal-title":"Medicine"},{"issue":"1","key":"4584_CR85","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1097\/00054725-200501000-00004","volume":"11","author":"SW Han","year":"2005","unstructured":"Han SW, McColl E, Barton JR, James P, Steen IN, Welfare MR. Predictors of quality of life in ulcerative colitis: the importance of symptoms and illness representations. Inflamm Bowel Dis. 2005;11(1):24\u201334.","journal-title":"Inflamm Bowel Dis"},{"issue":"11","key":"4584_CR86","doi-asserted-by":"publisher","first-page":"585","DOI":"10.1016\/j.kjms.2015.10.001","volume":"31","author":"AK Demir","year":"2015","unstructured":"Demir AK, Demirtas A, Kaya SU, Tastan I, Butun I, Sagcan M, et al. The relationship between the neutrophil-lymphocyte ratio and disease activity in patients with ulcerative colitis. Kaohsiung J Med Sci. 2015;31(11):585\u201390.","journal-title":"Kaohsiung J Med Sci"}],"container-title":["BMC Gastroenterology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12876-025-04584-6","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12876-025-04584-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12876-025-04584-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,2,4]],"date-time":"2026-02-04T13:03:53Z","timestamp":1770210233000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12876-025-04584-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1,8]]},"references-count":86,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["4584"],"URL":"https:\/\/doi.org\/10.1186\/s12876-025-04584-6","relation":{},"ISSN":["1471-230X"],"issn-type":[{"value":"1471-230X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,1,8]]},"assertion":[{"value":"4 October 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 December 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 January 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Ethical approval was obtained from the Institutional Review Board of An-Najah National University, West Bank, Palestine. All participants were informed about the study\u2019s aims, procedures, risks, and benefits, and provided written informed consent. Confidentiality was strictly maintained, and the study complied with the Declaration of Helsinki.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"97"}}